Skip over main navigation
  • Sign up
  • Log in
  • Basket: (0 items)
Emerge Australia
  • Twitter
  • Facebook
  • Email
Donate Become a member
Menu
  • About us
    • What we do
    • Our team
    • Our Ambassador
    • Our impact
    • Annual reports
    • Contact us
  • ME/CFS information
    • What is ME/CFS?
    • Diagnosis
    • Treatment and management
    • What is fibromyalgia?
    • ME/CFS - what's in a name?
    • For health professionals
    • Member stories
  • Research
    • OMF Australia
    • ME/CFS biobank and registry
    • ANCHOR Study
    • Research Digest
    • Health and Wellbeing Survey
  • How to get help
    • InfoLine
    • Telehealth Nurse Service
    • Peer support groups
    • Accessing financial support
      • About NDIS
      • About DSP
      • Financial literacy resources for ME/CFS
  • Get involved
    • Give monthly
    • Donate
    • Fundraisers
    • Bequest giving
    • Emerge Australia Membership
    • Volunteer with us
    • Patient Advisory Group
    • Campaigns and advocacy resources
    • ME/CFS Awareness Day
  • Shop
  • News
    • News
  • Admin
    • Log in
  • Basket: (0 items)
  • What is ME/CFS?

What is ME/CFS?

Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a complex and disabling disease that affects many parts of the body, including the brain and muscles, as well as the digestive, immune and cardiac systems, among others. ME is classified as a neurological disorder by the World Health Organization.

Who can develop ME/CFS?

ME/CFS affects men, women and children of all ages, ethnicities, and socioeconomic backgrounds. 75-80% of people with the condition are female. Around 25% of people with ME/CFS experience severe symptoms, leaving them housebound or bedbound.

While estimates of how many people have ME/CFS vary, it is thought that around 0.4-1% of the population is affected. This means that up to 250,000 Australians have the condition.

What are the symptoms of ME/CFS?

People with ME/CFS experience a wide range of symptoms.

A common misconception is that people with ME/CFS have 'chronic fatigue', and are just tired. Chronic fatigue is a symptom of many conditions (for example, heart disease, cancer, multiple sclerosis, anaemia and ME/CFS), but it is not a condition in its own right. Persistent and profound fatigue is just one symptom of ME/CFS, as it is with a number of other conditions.

The central feature of ME/CFS is post-exertional malaise (PEM), which means that symptoms get worse after physical or mental activity. PEM is very disabling and causes fluctuations in a person’s health: what they may be able to do one day, they might not be able to do the next. The level of activity that triggers PEM varies. For some, it may be a short walk or writing a homework assignment. For people who are more severely unwell, it could be brushing their teeth or reading a sentence of a book. PEM is often delayed and can last days, weeks or months, making the illness difficult to manage.

Other common symptoms include:

  • sleep dysfunction
  • widespread pain in muscles or joints
  • cognitive difficulties, such as confusion, or problems with concentration or memory
  • sensitivity to noise or light
  • light-headedness or dizziness
  • difficulty with being upright
  • gastrointestinal problems such as nausea, abdominal pain, bloating and irritable bowel syndrome
  • flu-like symptoms
  • problems with temperature regulation
  • sensitivities to food, medications or chemicals

What causes ME/CFS?

The cause of ME/CFS is currently not known, although a number of factors may be involved, including:

  • infection (which is the most common trigger, but is not universal)
  • environmental toxins
  • physical trauma (such as surgery or car accident)
  • genetics (like many other chronic diseases, ME/CFS can run in families, although the specific genes involved haven’t yet been identified and more research is needed)
  • physical, mental or emotional stress may also contribute to the onset of the condition

For some people, ME/CFS comes on suddenly. For others, there is a gradual onset over months or years. It is not currently understood why there are these differences in how the illness starts.

While there are currently no diagnostic biomarkers or tests for ME/CFS, there are many biological abnormalities that researchers have found in people living with the condition. These include an abnormal physiological response to exercise, altered immune function, changes in the bacteria in the gut, and impaired energy production.

Access related pages easily using the links below:

Diagnosis                     

Treatment and management

ME/CFS – what's in a name?

What is fibromyalgia?

Published: 20th June, 2019

Updated: 9th June, 2020

Author:

Share this page
  • Email
  • Facebook
  • Twitter

Latest

  • Help us give the gift of knowledge this Christmas

    Help us give the gift of knowledge this Christmas

    People with ME/CFS face multiple challenges every day. Despite the devastating impact of this illness, thousands of Australians living with ME/CFS struggle to access high-quality, knowledgeable help.

  • Research Digest 11/12/20

    Research Digest 11/12/20

    Welcome to the 61st edition of the Research Digest. This fortnight's edition features a study investigating microRNA expression differences in ME/CFS patients before and after experiencing PEM, and a study that aimed to develop a sensor-based method to track upright activity as a way to measure ME/CFS disease severity.

  • Research Digest 27/11/20

    Research Digest 27/11/20

    Welcome to the 60th edition of the Research Digest featuring a study that aimed to determine whether there are differences in cardiac function in ME/CFS patients and a plasma proteomic analysis study.

  • New ME/CFS Clinical Guidelines for the UK

    New ME/CFS Clinical Guidelines for the UK

    The UK’s National Institute for Health and Care Excellence has published its long-awaited draft of the new ME/CFS clinical guidelines.

Most read

  • Open Medicine Foundation Australia

    Open Medicine Foundation Australia

    Emerge Australia is proud to be launching the 5th addition to a global network of OMF-established Collaborative Research Centres, with our partner, Open Medicine Foundation, seeing an Australian centre join with those at Harvard, Stanford, Uppsala, and Montreal universities.

  • Coronavirus and ME - Simplified facts

    Coronavirus and ME - Simplified facts

    Many people with ME/CFS and other vulnerable communities in Australia are concerned about the impacts of the spreading coronavirus disease COVID-19. This is an easy-read resource with the latest information and advice.

  • Australian Research Centre to Open Early in 2021

    Australian Research Centre to Open Early in 2021

    The new Australian ME/CFS Centre for Collaborative Research is expected to officially open early in 2021

  • Research Digest 30/10/20

    Welcome to the 58th edition of the Research Digest featuring a focus group study that aimed to gain insight into the PEM experiences of ME/CFS patients and a cluster analysis study defining subgroups of patients based on several measures of autonomic dysfunction.

  • Research Digest 04/09/20

    Welcome to the 54th edition of the Research Digest. This fortnight's edition includes summary of a functional MRI study exploring brain responses to autonomic challenges in ME/CFS patients with and without temporomandibular disorder.

  • Research Digest 13/11/20

    Research Digest 13/11/20

    Welcome to the 59th edition of the Research Digest. This issue features a review article on the eitology of ME/CFS and a systematic review of neuroimaging studies.

  • Research Digest 16/10/20

    Welcome to the 57th edition of the Research Digest featuring the results of the NHMRC ME/CFS Targeted Call for Research funding and a study that aimed to compare the subjective severity scoring of the SF-36 (based on the physical activity subscale) to two objective measures of activity in order to validate the way in which clinical severity is graded in ME/CFS.

  • What is ME/CFS?

    What is ME/CFS?

    Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a complex and disabling disease that affects many parts of the body, including the brain and muscles, as well as the digestive, immune and cardiac systems, among others.

  • What is fibromyalgia?

    Fibromyalgia is an associated condition of ME/CFS

  • Accessibility

Join our community

* indicates required


Specific mailing lists

Helpful links

  • Sitemap
  • Accessibility
  • Terms & Conditions
  • Privacy Policy

Connect with us

  • Twitter
  • Facebook
  • YouTube


Get in touch with us

Emerge Australia
Ross House
247 - 251 Flinders Lane
Melbourne VIC 3000
1800 865 321
03 9529 1344
 

Emerge Australia is registered as a charity with the Australian Charities and Not-for-profits Commission (ACNC). We are authorised by the Australian Tax Office as a deductible gift recipient (DGR). 

ABN/DGR: 22 385 438 041

Donations of $2 or more are tax-deductible. 

Emerge Australia acknowledges Aboriginal and Torres Strait Islander people as the Traditional Custodians of the land and pays respect to their Elders past and present.

© 2019 Emerge Australia. All rights reserved.